| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 08/01/2007 | EP1287134B1 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | EP1141293B1 Vascular endothelial growth factor-x |
| 08/01/2007 | CN1329519C Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process |
| 08/01/2007 | CN1329409C Modulation of the expression of genes dependent on STAT-1 |
| 08/01/2007 | CN1329393C New purine derivatives |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329359C Ether compounds, compositions, and uses thereof |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN1329066C Injectio for activating pulse and its preparing method |
| 08/01/2007 | CN1329037C Intravenous inject contg. pseudo-ginseng total saponin and its prodn. method |
| 08/01/2007 | CN1329035C Method for preparing medicine composition contg. aspirin |
| 08/01/2007 | CN1329032C Non-sedating barbiturate compounds as neuroprotective agents |
| 08/01/2007 | CN1329026C Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 08/01/2007 | CN101010323A Bicyclononene derivatives as renin inhibitors |
| 08/01/2007 | CN101010300A 2-phenylpyridine derivative |
| 08/01/2007 | CN101010102A Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 08/01/2007 | CN101010101A Composition comprising protein material and non-oxidizable fatty acid entities |
| 08/01/2007 | CN101007992A Health white spirit containing beneficial functional component |
| 08/01/2007 | CN101007841A Method for separating and purifying ACE inhibition peptide from rice draff and active peptide obtained therefor |
| 08/01/2007 | CN101007829A 1,6-diphospho-D-fructose ester arginine salt and its pharmaceutical uses |
| 08/01/2007 | CN101007804A 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007798A Benzodioxole derivatives and their preparation method and medicinal uses |
| 08/01/2007 | CN101007794A N,N'-disubstituted piperazine derivative, and its preparation method and medicinal composition and uses |
| 08/01/2007 | CN101007791A Amino acid diphenyl compound |
| 08/01/2007 | CN101007173A Anti-angiogene compositions and methods of use |
| 08/01/2007 | CN101007166A Use of derivatives of erythropoietin carbamylated in preparation of medicine |
| 08/01/2007 | CN101007162A Medicine bag containing traditional Chinese medicine for physiotherapy |
| 08/01/2007 | CN101007146A A pure Chinese medicine preparation for decreasing blood pressure and resuming function of brain cell |
| 08/01/2007 | CN101007124A A traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparation method |
| 08/01/2007 | CN101007079A An extraction method of total flavones from hawthorn extract |
| 08/01/2007 | CN101007074A Preparing method of Ginseng and Aconite preparation for injection |
| 08/01/2007 | CN101007057A Extraction method of water soluble components from salvia miltiorrhiza by ultrasonic continuous countercurrent gradient |
| 08/01/2007 | CN101007055A Preparation method of pollen of eucommia ulmoides soft capsules containing alpha-linolenic acid |
| 08/01/2007 | CN101007051A Chinese medicine pillow capable of treating hypertension |
| 08/01/2007 | CN101007038A Hypotensive portion of Hebei chrysanthemum extracts, extracting method and application in pharmaceutics thereof |
| 08/01/2007 | CN101007027A Application method of neural regulation protein in the treatment of cardiovascular diseases and its composition |
| 08/01/2007 | CN101007024A Spirulina containing active peptide, protease and protein kinase, and its processing method and application |
| 08/01/2007 | CN101007014A A compound puerarin preparation |
| 08/01/2007 | CN101007013A Liposome of astragaloside IV and its medicinal preparation |
| 08/01/2007 | CN101007001A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101007000A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006999A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006995A Application of isosteviol in pharmacy |
| 08/01/2007 | CN101006984A An injection preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application |
| 08/01/2007 | CN101006975A An oral medicine preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application |
| 08/01/2007 | CN101006846A Anti-stress nutrition additives for poultry and its preparation method |
| 08/01/2007 | CN101006818A A processing method of ginkgo flower tea |
| 08/01/2007 | CN101006813A A prepared tea combined by oolong tea with green tea or white tea |
| 08/01/2007 | CN101006807A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006806A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006805A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 07/31/2007 | US7251525 Treating or preventing arrhythmias in a human subject comprising the administration of an effective amount of a calcium/calmodulin-dependent protein kinase inhibitor. Also provided are pharmaceutical compositions as antiarrhythmia |
| 07/31/2007 | US7250531 Process for the synthesis and crystalline form of agomelatine |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250442 glucocorticoid, androgen, mineralcorticoid, estrogen and progesterone receptor modulators such as 3,3-Bis-(4-hydroxy-3,5-dimethyl-phenyl)-1-(4-methoxy-benzyl)-1,3-dihydro-indol-2-one, used for treating congestive heart failure |
| 07/31/2007 | US7250429 Aminomethyl-substituted thiazolobenzimidazole compounds |
| 07/31/2007 | US7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 07/31/2007 | US7250411 Benzothiazine and benzothiadiazine compounds |
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/31/2007 | CA2398353C Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/31/2007 | CA2240705C Cyclosporin-containing soft capsule preparations |
| 07/31/2007 | CA2191645C Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
| 07/26/2007 | WO2007084868A2 Treatment of disorders by activation of the unfolded protein response |
| 07/26/2007 | WO2007084857A2 Methods and compositions for treating cell proliferative disorders |
| 07/26/2007 | WO2007083689A1 Plasminogen activator inhibitor-1 inhibitor |
| 07/26/2007 | WO2007083611A1 Spontaneous pulmonary hypertension model animal, method for production of the model animal, pharmaceutical composition for pulmonary hypertension, and therapeutic method for pulmonary hypertension |
| 07/26/2007 | WO2007083603A1 Therapeutic agent |
| 07/26/2007 | WO2007083098A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 07/26/2007 | WO2007082907A1 Substituted 4-phenylpiperidines |
| 07/26/2007 | WO2007082822A1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 07/26/2007 | WO2007058634B1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 07/26/2007 | WO2007044441A3 Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 07/26/2007 | WO2007037850A3 Enhanced delivery of cells |
| 07/26/2007 | WO2007028110A3 Methods for using and identifying modulators of delta-like 4 |
| 07/26/2007 | WO2007025274A3 Self-assembling nanoparticles for the treatment of vascular diseases |
| 07/26/2007 | WO2007008541A3 Cellular cholesterol absorption modifiers |
| 07/26/2007 | WO2007003948A3 Core 2 glcnac-t inhibitors |
| 07/26/2007 | WO2006122154A3 Pyridone derivatives for modulating stress-activated protein kinase system |
| 07/26/2007 | WO2006102728A3 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases |
| 07/26/2007 | WO2006079625A3 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173537 Indazole compound and pharmaceutical use thereof |
| 07/26/2007 | US20070173518 Crystal of ticagrelor; G-protein coupled receptor antagonist, used for treating arterial thrombotic complications |
| 07/26/2007 | US20070173507 Dairyl-substituted five-membered heterocycle derivative |
| 07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172893 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |